10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
7:06 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/16/2024
3:50 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
3:38 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/15/2024
7:04 AM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
10/03/2024
7:09 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
10/01/2024
3:03 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
|
09/23/2024
5:00 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/18/2024
8:19 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/16/2024
3:34 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
09/13/2024
4:14 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:10 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:11 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/13/2024
4:13 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/09/2024
8:09 AM | Akero Therapeutics (Subject)
WELLINGTON MANAGEMENT GROUP LLP (Filed by)
| Form SC 13G/A | |
09/05/2024
3:05 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
09/05/2024
3:08 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/29/2024
3:30 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/28/2024
10:11 AM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/26/2024
3:32 PM | Akero Therapeutics (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/23/2024
3:27 PM | Akero Therapeutics (Subject)
Yale Catriona (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
08/20/2024
10:45 AM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
08/09/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
08/09/2024
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
08/02/2024
8:32 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/25/2024
4:54 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/24/2024
3:25 PM | Akero Therapeutics (Subject)
White William Richard (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
07/18/2024
8:41 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:55 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:55 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:56 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:56 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
07/02/2024
5:57 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:01 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:04 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:06 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:09 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:11 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/13/2024
5:13 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/12/2024
4:23 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
Trump or Kamala? It may come down to this strange twist… (Ad) Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia?
To uncover the full story and learn how you can potentially profit from it... watch my new documentary here. |
06/11/2024
4:20 PM | Akero Therapeutics (Issuer)
Judy Chou (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:22 PM | Akero Therapeutics (Issuer)
Harrison Seth Loring (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:24 PM | Akero Therapeutics (Issuer)
Henderson Jane (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:25 PM | Akero Therapeutics (Issuer)
Heyman Tomas J. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:28 PM | Akero Therapeutics (Issuer)
Iwicki Mark T (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:29 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/11/2024
4:31 PM | Akero Therapeutics (Issuer)
Xu Yuan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
06/10/2024
3:17 PM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
06/05/2024
4:05 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/10/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-Q
General form for quarterly reports under Section 13 or 15(d) | |
05/10/2024
6:17 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
05/02/2024
8:07 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
05/01/2024
6:32 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 3
Initial statement of beneficial ownership of securities | |
05/01/2024
6:36 PM | Akero Therapeutics (Issuer)
Gangloff Scott A. (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/16/2024
3:30 PM | Akero Therapeutics (Filer)
| Form PRE 14A | |
04/03/2024
5:55 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
04/01/2024
3:17 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/18/2024
3:31 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:42 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:43 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:44 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
3:45 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/15/2024
9:08 AM | Akero Therapeutics (Subject)
GENERAL ATLANTIC, L.P. (Filed by)
| Form SC 13G | |
03/06/2024
7:13 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
7:14 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/06/2024
4:25 PM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
03/06/2024
4:16 PM | Akero Therapeutics (Filer)
| Form 424B5 | |
03/05/2024
4:16 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
03/04/2024
4:30 PM | Akero Therapeutics (Subject)
Cheng Andrew (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
03/04/2024
6:55 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/29/2024
3:42 PM | Akero Therapeutics (Filer)
| Form S-8
Registration statement under Securities Act of 1933 to be offered to employees pursuant to certain plans | |
02/29/2024
6:30 AM | Akero Therapeutics (Filer)
| Form 10-K
Annual report pursuant to Section 13 or 15(d) | |
02/29/2024
6:15 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
02/14/2024
1:19 PM | Akero Therapeutics (Subject)
PFIZER INC (Filed by)
| Form SC 13G/A | |
02/14/2024
6:06 AM | Akero Therapeutics (Subject)
RTW INVESTMENTS, LP (Filed by)
| Form SC 13G | |
02/13/2024
8:40 PM | Akero Therapeutics (Subject)
Avidity Partners Management LP (Filed by)
| Form SC 13G/A | |
02/13/2024
5:30 PM | Akero Therapeutics (Subject)
ALKEON CAPITAL MANAGEMENT LLC (Filed by)
| Form SC 13G/A | |
02/13/2024
10:31 AM | Akero Therapeutics (Subject)
JANUS HENDERSON GROUP PLC (Filed by)
| Form SC 13G/A | |
02/07/2024
6:23 AM | ADAGE CAPITAL PARTNERS GP, L.L.C. (Filed by)
Akero Therapeutics (Subject)
| Form SC 13G/A | |
01/25/2024
8:36 AM | Akero Therapeutics (Subject)
STATE STREET CORP (Filed by)
| Form SC 13G/A | |
12/29/2023
7:30 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/29/2023
5:07 PM | Akero Therapeutics (Subject)
Young Jonathan (Reporting)
| Form 144
Notice of proposed sale of securities pursuant to Rule 144 | |
12/18/2023
7:49 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:37 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:39 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:40 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
7:29 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/18/2023
6:08 AM | Akero Therapeutics (Filer)
| Form 8-K
Current report pursuant to Section 13 or 15(d) | |
12/12/2023
3:43 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
Trump or Kamala? It may come down to this strange twist… (Ad) Could this be the key to America's second coming? A strange resurrection born in the hollers of Appalachia?
To uncover the full story and learn how you can potentially profit from it... watch my new documentary here. |
12/12/2023
3:43 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:35 PM | Akero Therapeutics (Issuer)
Lamy Patrick (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:38 PM | Akero Therapeutics (Issuer)
Rolph Timothy (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/12/2023
3:26 PM | Akero Therapeutics (Issuer)
Yale Catriona (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
7:59 PM | Akero Therapeutics (Issuer)
Cheng Andrew (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/11/2023
8:06 PM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
12/05/2023
7:37 AM | Akero Therapeutics (Issuer)
Graham G. Walmsley (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/21/2023
4:30 PM | Akero Therapeutics (Issuer)
Young Jonathan (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
11/13/2023
4:37 PM | Akero Therapeutics (Issuer)
White William Richard (Reporting)
| Form 4
Statement of changes in beneficial ownership of securities | |
